相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
David T. Felson et al.
ARTHRITIS AND RHEUMATISM (2011)
Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic matrix design
Jeremy A. Rassen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Direct Comparison of Treatment Responses, Remission Rates, and Drug Adherence in Patients With Rheumatoid Arthritis Treated With Adalimumab, Etanercept, or Infliximab Results From Eight Years of Surveillance of Clinical Practice in the Nationwide Danish DANBIO Registry
Merete Lund Hetland et al.
ARTHRITIS AND RHEUMATISM (2010)
Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis
Peter C. Taylor et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA:: results from the South Swedish Arthritis Treatment Group Register
L. E. Kristensen et al.
RHEUMATOLOGY (2008)
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care
Daniel Aletaha et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2007)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
FC Breedveld et al.
ARTHRITIS AND RHEUMATISM (2006)
Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
JJ Gomez-Reino et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Tumor necrosis factor inhibitors: Clinical implications of their different immunogenicity profiles
PJ Anderson
SEMINARS IN ARTHRITIS AND RHEUMATISM (2005)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense
R van Vollenhoven et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)